免疫检查点B7-H4在消化系统恶性肿瘤中的研究进展

Research progress on B7-H4 immune checkpoint in malignant digestive system tumors

  • 摘要: 消化系统恶性肿瘤是中国癌症相关死亡的重要原因之一,其复杂的分子机制一直是临床和基础研究领域的焦点。B7-H4作为免疫球蛋白超家族B7家族的一员,具备多种生物学功能,主要通过抑制T细胞的活化和增殖、阻断细胞因子的合成来降低免疫响应。该蛋白在多种肿瘤组织中表达增高,与肿瘤细胞的增殖、分化、凋亡以及侵袭和转移密切相关,并且其表达水平与患者的预后紧密相连。尽管B7-H4在肿瘤的发生和发展中起着至关重要的作用,但其具体作用机制尚待进一步明确。本文就消化系统恶性肿瘤中B7-H4的研究进展进行综述,以期为未来的研究提供新的方向。

     

    Abstract: Malignant digestive system tumors are a leading cause of cancer-related deaths in China, drawing significant attention in clinical and basic research owing to their complex molecular mechanisms. B7-H4, a member of the B7 protein family within the immunoglobulin superfamily, exerts various biological functions, primarily inhibiting T-cell activation and proliferation and blocking cytokine synthesis, thereby suppressing the immune response. Overexpression of B7-H4 in various tumor tissues is closely associated with tumor cell proliferation, differentiation, apoptosis, invasion, metastasis, and correlates with patient prognosis. Despite its crucial role in tumor onset and progression, the specific mechanism of B7-H4 action remains unclear. This article reviews the research progress on B7-H4 in gastrointestinal tumors, aiming to provide new perspectives for future studies.

     

/

返回文章
返回